Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical intraepithelial neoplasia and cervical infection in young Japanese women: Open follow-up of a randomized clinical trial up to 4 years post-vaccination

In this open, extended follow-up study (NCT00929526, Clinicaltrials.gov), we evaluated the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine efficacy, immunogenicity and safety up to 4 years after first vaccination in Japanese women aged 20–25 years. In the initial randomized, double-blind st...

Descripción completa

Detalles Bibliográficos
Autores principales: Konno, Ryo, Yoshikawa, Hiroyuki, Okutani, Marie, Quint, Wim, V Suryakiran, Pemmaraju, Lin, Lan, Struyf, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186043/
https://www.ncbi.nlm.nih.gov/pubmed/25424783
http://dx.doi.org/10.4161/hv.28712

Ejemplares similares

Ejemplares similares